Marilena Cesari

5PUBLICATIONS
49CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Diagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Emanuela Palmerini, Cristina Meazza, Angela Tamburini

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

|Jan 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano

|May 07, 2019
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?

Emanuela Palmerini, Elisa Torricelli, Stefano Cascinu

|Feb 07, 2019
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution.

Marilena Cesari, Alberto Righi, Marco Colangeli

Pageof 1

Frequent Collaborators

5 joint publications

Emanuela Palmerini

3 joint publications

Franca Fagioli

3 joint publications

Toni Ibrahim

3 joint publications

Sebastian Dorin Asaftei